Alaunos Therapeutics Inc TCRT:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 04/24/24 EDT
1.18UNCH (UNCH)
Volume
30,188
52 week range
0.66 - 10.47
Loading...
  • Open1.18
  • Day High1.31
  • Day Low1.17
  • Prev Close1.18
  • 52 Week High10.47
  • 52 Week High Date05/16/23
  • 52 Week Low0.66
  • 52 Week Low Date12/12/23

Key Stats

  • Market Cap18.895M
  • Shares Out16.01M
  • 10 Day Average Volume0.05M
  • Dividend-
  • Dividend Yield-
  • Beta-0.26
  • YTD % Change11.27

KEY STATS

  • Open1.18
  • Day High1.31
  • Day Low1.17
  • Prev Close1.18
  • 52 Week High10.47
  • 52 Week High Date05/16/23
  • 52 Week Low0.66
  • 52 Week Low Date12/12/23
  • Market Cap18.895M
  • Shares Out16.01M
  • 10 Day Average Volume0.05M
  • Dividend-
  • Dividend Yield-
  • Beta-0.26
  • YTD % Change11.27

RATIOS/PROFITABILITY

  • EPS (TTM)-2.20
  • P/E (TTM)-0.54
  • Fwd P/E (NTM)-0.66
  • EBITDA (TTM)-26.178M
  • ROE (TTM)-156.66%
  • Revenue (TTM)5,000.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-702,800.00%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date05/08/2024
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Alaunos Therapeutics Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Alaunos Therapeutics, Inc. is a clinical-stage oncology-focused cell therapy company. The Company is focused on exploring strategic alternatives, including, but not limited to, an acquisition, merger, reverse merger, sale of assets, strategic partnerships, capital raises or other transactions. Separately, the Company is evaluating several potential in-licensing opportunities in obesity, oncology and virology.
Holger Weis CPA
Independent Chairman of the Board
Dale Hogue Jr.
Interim Chief Executive Officer, Director
Abhishek Srivastava Ph.D.
Vice President - Technical Operations
Ferdinand Groenewald
Vice President - Finance
Address
2617 Bissonnet St, Suite 225
Houston, TX
77005
United States

Top Peers

SYMBOLLASTCHG%CHG
CALC
CalciMedica Inc
5.45UNCHUNCH
CKPT
Checkpoint Therapeutics Inc
1.44UNCHUNCH
INAB
IN8BIO, Inc.
1.06UNCHUNCH
NXTC
NextCure Inc
1.44UNCHUNCH
TIL
Instil Bio Inc
10.60UNCHUNCH